soft tissue sarcoma

Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
Medical Marketing and Media
Tue, 07/11/23 - 11:27 pm
JNJ
Janssen
Nanobiotix
NBTXR3
soft tissue sarcoma
Hensify
Australia-based Telix Pharmaceuticals inks oncology deal with Eli Lilly
Bio Spectrum Asia
Mon, 04/11/22 - 10:36 am
Telix Pharmaceuticals
Eli Lilly
radiopharmaceuticals
olaratumab
soft tissue sarcoma
As it takes Lartruvo off the shelves, Lilly is setting up program to provide drug access to current patients
Endpoints
Thu, 04/25/19 - 12:00 pm
Eli Lilly
Lartruvo
soft tissue sarcoma
On heels of Loxo buy, Lartruvo setback deals a blow to Lilly's oncology hopes
Fierce Pharma
Fri, 01/18/19 - 11:30 am
Eli Lilly
Lartruvo
soft tissue sarcoma
clinical trials
Nanobiotix Achieves Primary and Secondary Endpoints in Ph II/III Study in Soft Tissue Sarcoma with NBTXR3
CP Wire
Fri, 06/22/18 - 10:14 am
Nanobiotix
NBTXR3
soft tissue sarcoma
Immune Design Poised on Progress of Pipeline Candidates
Yahoo/Zacks.com
Mon, 03/19/18 - 11:50 am
Immune Design
CMB305
soft tissue sarcoma
G100
Biotech billionaire Soon-Shiong picks up rights to CytRx’s troubled cancer drug
Endpoints
Fri, 07/28/17 - 11:33 am
biotech
Dr. Patrick Soon-Shiong
CytRx
NantCell
NantWorks
doxorubicin
soft tissue sarcoma
FDA grants accelerated approval to Lilly's soft tissue sarcoma drug
Yahoo/Reuters
Wed, 10/19/16 - 06:44 pm
FDA
Eli Lilly
soft tissue sarcoma
Lartruvo
CytRx Awaiting Soft Tissue Sarcoma Data In December
Seeking Alpha
Thu, 10/17/13 - 09:51 am
CytRx
soft tissue sarcoma
aldoxorubicin